SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-050363
Filing Date
2023-04-26
Accepted
2023-04-26 16:16:42
Documents
14
Period of Report
2023-04-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2313816d1_8k.htm   iXBRL 8-K 27105
2 EXHIBIT 99.1 tm2313816d1_ex99-1.htm EX-99.1 13933
3 GRAPHIC tm2313816d1_ex99-1img001.jpg GRAPHIC 14509
  Complete submission text file 0001104659-23-050363.txt   239804

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lptx-20230426.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20230426_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20230426_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2313816d1_8k_htm.xml XML 3598
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 23849951
SIC: 2834 Pharmaceutical Preparations